American Century Companies’s Monte Rosa Therapeutics GLUE Stock Holding History

American Century Companies's GLUE Position: Q2 2026 in Review

American Century Companies reduced its Monte Rosa Therapeutics (GLUE) stake by 42% in Q2 2026, selling an estimated $22.4M and leaving 1,622,846 shares worth $39.3M. The position accounts for 0.02% of the portfolio, ranked #964.

American Century Companies first reported a position in GLUE in Q2 2023 and has held it in 13 quarters since. The position peaked at $46.2M in Q1 2026. 175 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

• American Century Companies held 1,622,846 shares of Monte Rosa Therapeutics worth $39.3M as of Q2 2026.
• American Century Companies sold 1,186,801 Monte Rosa Therapeutics shares in Q2 2026, an estimated $22.4M.
• Monte Rosa Therapeutics made up 0.02% of American Century Companies's portfolio in Q2 2026, its #964 holding.
• American Century Companies first reported a position in Monte Rosa Therapeutics in Q2 2023 and has held it in 13 quarters since.
• American Century Companies's Monte Rosa Therapeutics position peaked at $46.2M in Q1 2026.
• 175 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.